Monday's price guesses., page-52

On second thoughts, this looks premature actually, as the first specialty variation trials will occur in sep quarter. What I was alluding to actually is that there are different ratios of Edencrete vs. concrete and even at much lower dosage there has been significant measured benefits. So there might be a marketing development for EDE to work with identified 3rd parties to promote the product use at lower dosages. They may have customers willing to adopt the lower dosage/incremental cost on their project based on demonstrated benefits in the field trials. Hum just one more sleep, and we will soon find out. Cheers.